Xinbing Sui

23.5k total citations · 8 hit papers
128 papers, 7.5k citations indexed

About

Xinbing Sui is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Xinbing Sui has authored 128 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 30 papers in Oncology and 25 papers in Epidemiology. Recurrent topics in Xinbing Sui's work include Autophagy in Disease and Therapy (21 papers), Cancer-related molecular mechanisms research (14 papers) and RNA modifications and cancer (13 papers). Xinbing Sui is often cited by papers focused on Autophagy in Disease and Therapy (21 papers), Cancer-related molecular mechanisms research (14 papers) and RNA modifications and cancer (13 papers). Xinbing Sui collaborates with scholars based in China, Macao and United States. Xinbing Sui's co-authors include Hongming Pan, Weidong Han, Na Kong, Chao He, Tian Xie, Jichun Zhou, Shuiping Liu, Xian Wang, Qin Zhang and Li Ye and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Xinbing Sui

120 papers receiving 7.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

2013 1.0k citations Xinbing Sui, Weidong Han et al. profile →
p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents

2013 815 citations Xinbing Sui, Weidong Han et al. Cancer Letters profile →
The emerging role of ferroptosis in inflammation

2020 568 citations Yitian Sun, Xiang Yu et al. profile →
RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer

2018 546 citations Xinbing Sui, Ruonan Zhang et al. Frontiers in Pharmacology profile →
The role of STAT3 in autophagy

2015 418 citations Liangkun You, Zhanggui Wang et al. profile →
In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment

2020 308 citations Xinbing Sui et al. profile →
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment

2022 179 citations Quan Gao, Jiao Feng et al. Advanced Drug Delivery Reviews profile →
Intravesical delivery of KDM6A -mRNA via mucoadhesive nanoparticles inhibits the metastasis of bladder cancer

2022 128 citations Ruonan Zhang, Xinbing Sui et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xinbing Sui China	40	4.2k	2.0k	1.7k	1.5k	1.1k	128	7.5k
Hongming Pan China	46	3.8k 0.9×	1.8k 0.9×	2.3k 1.4×	1.8k 1.2×	3.1k 2.8×	222	9.2k
Xin Li China	55	5.5k 1.3×	3.4k 1.7×	746 0.4×	1.0k 0.7×	1.9k 1.7×	390	9.6k
Bülent Özpolat United States	45	4.3k 1.0×	1.7k 0.8×	931 0.6×	463 0.3×	904 0.8×	147	6.4k
Ioana Berindan‐Neagoe Romania	52	5.6k 1.3×	3.7k 1.9×	538 0.3×	629 0.4×	1.1k 1.0×	351	9.3k
Kiavash Hushmandi Iran	50	4.1k 1.0×	2.5k 1.2×	470 0.3×	660 0.4×	1.1k 1.0×	197	6.8k
Sujit K. Bhutia India	50	4.1k 1.0×	1.2k 0.6×	2.0k 1.2×	363 0.2×	1.4k 1.3×	165	7.8k
Xueying Sun China	48	3.4k 0.8×	1.7k 0.9×	833 0.5×	451 0.3×	1.2k 1.1×	187	6.8k
David A. Gewirtz United States	53	4.4k 1.0×	1.1k 0.5×	1.9k 1.1×	509 0.3×	2.2k 2.0×	192	8.1k
Xizhong Shen China	47	3.9k 0.9×	1.4k 0.7×	1.0k 0.6×	414 0.3×	799 0.7×	181	6.7k
Min Shi China	39	3.5k 0.8×	2.1k 1.0×	509 0.3×	1.6k 1.1×	1.6k 1.5×	164	6.7k

Countries citing papers authored by Xinbing Sui

Since Specialization

Citations

This map shows the geographic impact of Xinbing Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinbing Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinbing Sui more than expected).

Fields of papers citing papers by Xinbing Sui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinbing Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinbing Sui. The network helps show where Xinbing Sui may publish in the future.

Co-authorship network of co-authors of Xinbing Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Xinbing Sui. A scholar is included among the top collaborators of Xinbing Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinbing Sui. Xinbing Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gu, Xiaoqing, Quan Gao, Yanlin Huang, et al.. (2025). The antitumor mechanisms of Huangqin Houpo decoction and its effect on chemotherapy-induced toxicity in colorectal cancer. Phytomedicine. 150. 157424–157424.

Sun, Xueni, Jing Xia, Chunli Zhang, et al.. (2025). Single-cell and spatial transcriptome profiling identifies cellular heterogeneity and immunosuppressive tumor microenvironment in inflammatory breast cancer. Journal of Advanced Research. 81. 637–656.

Sun, Jing, et al.. (2025). Artemisiae Annuae Herba: from anti-malarial legacy to emerging anti-cancer potential. Theranostics. 15(15). 7346–7377.

Sun, Xueni, Haiyang Jiang, Xiaoyu Sun, et al.. (2025). Poricoic Acid A, an Active Ingredient Extracted From Poria cocos, Inhibits Lung Cancer Cell Growth by Suppressing MEK/ERK Signaling Pathway. Phytotherapy Research. 39(10). 4642–4657.

Zhang, Aili, Xueni Sun, Qibiao Wu, et al.. (2025). InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs. Scientific Reports. 15(1). 24616–24616.

Gao, Quan, Qinsong Sheng, Zhiyu Zhu, et al.. (2025). Honokiol‐Magnolol‐Baicalin Possesses Synergistic Anticancer Potential and Enhances the Efficacy of Anti‐PD‐1 Immunotherapy in Colorectal Cancer by Triggering GSDME‐Dependent Pyroptosis. Advanced Science. 12(13). e2417022–e2417022. 9 indexed citations

Zhu, Qianru, Ruonan Zhang, Xiaoqing Gu, et al.. (2024). Honokiol enhances the sensitivity of cetuximab in KRAS^G13D mutant colorectal cancer through destroying SNX3-retromer complex. Theranostics. 14(14). 5443–5460. 2 indexed citations

Zhao, Xiaohong, et al.. (2024). Modulating Endoplasmic Reticulum Stress in Gastrointestinal Cancers: Insights from Traditional Chinese Medicine. Pharmaceuticals. 17(12). 1599–1599. 2 indexed citations

Sun, Yitian, Qinyi Li, Guohua Li, et al.. (2024). Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance. Chinese Medicine. 19(1). 110–110. 6 indexed citations

10.

Huang, Xiaoyu, Xiaolong Zhu, Huan Yang, et al.. (2024). Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment. Molecules. 29(7). 1462–1462. 5 indexed citations

11.

He, Jun, et al.. (2024). Drug tolerant persister cell plasticity in cancer: a revolutionary strategy for more effective anticancer therapies. Signal Transduction and Targeted Therapy. 9(1). 209–209. 29 indexed citations

12.

Wang, Deqiang, Xiaofeng Chen, Yian Du, et al.. (2022). Associations of HER2 Mutation With Immune-Related Features and Immunotherapy Outcomes in Solid Tumors. Frontiers in Immunology. 13. 799988–799988. 13 indexed citations

13.

Gao, Quan, Jiao Feng, Wen‐Cheng Liu, et al.. (2022). Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. Advanced Drug Delivery Reviews. 188. 114445–114445. 179 indexed citations breakdown →

14.

Wang, Jue, Cong Xu, Ying Chen, et al.. (2021). β-elemene enhances the antitumor activity of erlotinib by inducing apoptosis through AMPK and MAPK pathways in TKI-resistant H1975 lung cancer cells. Journal of Cancer. 12(8). 2285–2294. 22 indexed citations

15.

Huang, Xingxing, Ting Pan, Lili Yan, et al.. (2020). The inflammatory microenvironment and the urinary microbiome in the initiation and progression of bladder cancer. Genes & Diseases. 8(6). 781–797. 24 indexed citations

16.

Li, Yicong, Xinbing Sui, Zeqi Su, et al.. (2020). Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment. Frontiers in Pharmacology. 11. 132–132. 23 indexed citations

17.

Zhao, Jing, Xinbing Sui, Junlin Yao, et al.. (2016). SKF-96365 activates cytoprotective autophagy to delay apoptosis in colorectal cancer cells through inhibition of the calcium/CaMKIIγ/AKT-mediated pathway. Cancer Letters. 372(2). 226–238. 66 indexed citations

18.

Pan, Hongming, Zhanggui Wang, Liming Jiang, et al.. (2014). Autophagy inhibition sensitizes hepatocellular carcinoma to the multikinase inhibitor linifanib. Scientific Reports. 4(1). 6683–6683. 58 indexed citations

19.

Sui, Xinbing. (2007). Mechanism of salvianolate in preventing postoperative intestinal adhesion in rats. Journal of Chinese Integrative Medicine. 5(5). 521–525. 5 indexed citations

20.

Zamponi, Gerald W., Xinbing Sui, Penelope W. Codding, & Robert J. French. (1993). Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation. Biophysical Journal. 65(6). 2324–2334. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact